Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

NYU/Bellevue WTC Health Impacts Research Registry

This study is currently recruiting participants. (see Contacts and Locations)
Verified June 2016 by New York University School of Medicine
Sponsor:
Collaborator:
National Institute for Occupational Safety and Health (NIOSH/CDC)
Information provided by (Responsible Party):
New York University School of Medicine
ClinicalTrials.gov Identifier:
NCT00404898
First received: November 28, 2006
Last updated: June 1, 2016
Last verified: June 2016
  Purpose
The American Red Cross has funded a multidisciplinary, comprehensive evaluation and treatment program for target individuals with suspected World Trade Center (WTC)-related health problems. The populations served consist predominantly of a) local residents who were impacted by the disperion of the WTC dusts and fumes, b) individuals involved in cleaning and debris removal of local commercial spaces, and c) responders to the WTC collapse. These populations are recruited from past and ongoing programs that we have developed as well as from ongoing collaborations with community organizations that include: the Beyond Ground Zero Network, 9/11 Environmental Action committee, and the WTC Residents Coalition. In addition, there is collaboration with the Charles B. Wang Community Health Center and the centers involved in the ongoing WTC Workers and Volunteer Medical Screening and Monitoring Program. We would now like to access the data from this treatment program to create a NYU/Bellevue WTC Health Impacts Research Registry to increase knowledge about the health effects of exposure to World Trade Center dust.

Condition
Exposure to World Trade Center Dust

Study Type: Observational
Study Design: Time Perspective: Retrospective
Official Title: NYU/Bellevue Red Cross WTC Health Impacts Research Registry

Further study details as provided by New York University School of Medicine:

Primary Outcome Measures:
  • Respiratory Status [ Time Frame: June 2020 ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Mental Health Status [ Time Frame: June 2020 ] [ Designated as safety issue: No ]
  • General Health Status [ Time Frame: June 2020 ] [ Designated as safety issue: No ]

Estimated Enrollment: 7000
Study Start Date: December 2007
Estimated Primary Completion Date: June 2019 (Final data collection date for primary outcome measure)
  Eligibility

Ages Eligible for Study:   Child, Adult, Senior
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population
The populations to be served will consist predominantly of a) local residents who were impacted by the dispersion of the WTC dusts and fumes, b) individuals involved in cleaning and debris removal of local commercial spaces, and c) responders to the WTC collapse. These populations will be recruited from past and ongoing programs that we have developed as well as from ongoing collaborations with community organizations that include: the Beyond Ground Zero Network, 9/11 Environmental Action committee, and the WTC Residents Coalition.
Criteria

Target populations who will participate in the Bellevue Hospital Red Cross WTC Health Impacts Program will include:

  • residents (children and adults) of Lower Manhattan communities at the time of the attacks, who remained or returned to their homes soon after the attacks
  • individuals involved in debris removal in surrounding commercial and residential buildings,
  • individuals involved in rescue, recovery and debris removal who have been previously screened through the World Trade Center Worker and Volunteer Medical Screening Program and are in need of continued treatment.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00404898

Contacts
Contact: Waiwah Chung, RN 212 562 1719 Waiwah.Chung@bellevue.nychhc.org

Locations
United States, New York
NYU School of Medicine/Bellevue Hospital Recruiting
New York, New York, United States, 10016
Contact: Waiwah Chung, RN    212-562-1719    Waiwah.Chung@bellevue.nychhc.org   
Sub-Investigator: William Bateman         
Sub-Investigator: Denise Harrison, MD         
Sub-Investigator: Andrew Wallach         
Principal Investigator: Joan Reibman, MD         
Sponsors and Collaborators
New York University School of Medicine
National Institute for Occupational Safety and Health (NIOSH/CDC)
Investigators
Principal Investigator: Joan Reibman, MD New York University School of Medicine
  More Information

Responsible Party: New York University School of Medicine
ClinicalTrials.gov Identifier: NCT00404898     History of Changes
Obsolete Identifiers: NCT01751711
Other Study ID Numbers: 06-01 
Study First Received: November 28, 2006
Last Updated: June 1, 2016
Health Authority: United States: Institutional Review Board

Keywords provided by New York University School of Medicine:
World Trade Center dust

ClinicalTrials.gov processed this record on September 23, 2016